Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Drug Alcohol Depend. 2017 Dec 7;183:162–168. doi: 10.1016/j.drugalcdep.2017.10.022

Figure 1. Changes in Drug Stroop Performance across Treatment Period by Abstinence Outcome.

Figure 1

Within the completer sample (N=61), a significant time point (pre-, post-treatment) by trial type (drug, neutral) by longest duration of abstinence during treatment (3+ weeks; <3 weeks) reflected greater improvement in Drug Stroop performance (reduced slowing to drug-related stimuli relative to neutral stimuli) in the group that achieved longer (3+ weeks) abstinence during treatment, relative to the group with shorter abstinence duration. Color indicates abstinence outcome (black=3+ weeks continuous abstinence during treatment; gray=<3 weeks continuous abstinence during treatment). Line type indicates Drug Stroop trial type (solid=Drug trials; dotted=Neutral trials). RT= response time (in milliseconds).